As of May 24
| +0.66 / +0.23%|
The 28 analysts offering 12-month price forecasts for Biogen Inc have a median target of 358.50, with a high estimate of 425.00 and a low estimate of 272.00. The median estimate represents a +26.05% increase from the last price of 284.41.
The current consensus among 32 polled investment analysts is to Buy stock in Biogen Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.